Does oral administration of dabigatran etexilate, a direct thrombin inhibitor, achieve clinical significant concentrations of dabigatran and thrombin inhibiting activity in vitreous and subretinal fluid?
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2016
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Retinal detachment
- Focus Pharmacokinetics; Therapeutic Use
- 10 Jul 2014 New trial record